Telemedicine is supposed to be the part of modern health care that saves everyone a trip, a waiting room magazine, and at least one muttered complaint about parking. In South Carolina, that promise is real in many specialties. The state has embraced telehealth as a tool for access, efficiency, and long-distance care. But when the conversation turns to vision correction, the welcome mat suddenly gets yanked away.
That is the strange little plot twist at the center of South Carolina’s eye care policy. In most areas of medicine, lawmakers and regulators increasingly ask a sensible question: can a licensed clinician meet the same standard of care remotely as they would in person? If the answer is yes, telemedicine gets a chance. In eye care, though, South Carolina chose a different path. Instead of regulating outcomes and professional judgment, it carved out a rule that blocks prescriptions for glasses and contact lenses when they are based solely on data from online or kiosk-style vision testing.
The result is not just a legal oddity. It is a business climate problem, an access problem, and an innovation problem rolled into one pair of very expensive frames. South Carolina’s eye care laws do not merely slow a trendy app or frustrate one startup. They signal that telemedicine is welcome until it starts competing with a protected brick-and-mortar model. That is not a great look for a state that says it wants to expand access to care, support digital health, and encourage innovation.
The carve-out that makes South Carolina different
South Carolina’s broader telemedicine framework sounds modern enough. The state’s telemedicine law allows licensed clinicians to provide care remotely so long as they meet the same standard of care that would apply in person. That is a pretty normal way to regulate telehealth. It focuses on competence, documentation, medical judgment, and patient protection rather than acting like the internet itself is a contagious condition.
Then comes the eye care exception. Under South Carolina’s Eye Care Consumer Protection Law, a valid prescription for spectacles or contact lenses cannot be based solely on refractive error data generated by a “kiosk,” and the definition of kiosk is broad enough to include automated applications used on a phone, computer, or internet-based device. In plain English, if a licensed eye doctor reviews the results of an online vision test and thinks the patient is an appropriate candidate for a routine prescription renewal, South Carolina law still says that remote-only process cannot be the sole basis for the prescription.
That matters because refractive care is not some tiny niche. A huge share of adults rely on glasses or contacts, and many prescription renewals are routine. Yet South Carolina also requires prescriptions for spectacles and contact lenses to carry a one-year expiration date unless there is a medical reason for something shorter. So the state creates a recurring need for renewals, then blocks one of the most convenient ways to handle low-risk renewals. That is a policy design that feels a lot like building a toll road and then hiding the entrance.
Even former Gov. Nikki Haley saw the tension when she vetoed the bill in 2016. Her warning was blunt: South Carolina risked putting itself on the leading edge of protectionism, not innovation. The legislature overrode her veto anyway, and the law took effect. Years of litigation followed, eventually culminating in the South Carolina Supreme Court’s January 2026 decision to uphold the law under the state constitution.
Why supporters say the law protects patients
To be fair, supporters of the law are not making a silly argument. Their basic point is that a refraction is not the same thing as a full eye health evaluation. A person may need a new lens prescription and also have glaucoma risk, corneal issues, diabetic eye changes, hypertension-related findings, or other problems that a simple online refraction test will not catch. Contact lenses, in particular, raise extra safety concerns because poor fit, overwear, and corneal complications can become real medical issues.
This concern has institutional backing. The American Optometric Association and South Carolina optometry advocates have long argued that online vision tests can be misleading if consumers mistake them for comprehensive eye exams. Their position is that new technology should not be allowed to shortcut the standard of care, especially when patients may assume a digital convenience tool is a substitute for medical evaluation.
And they are right about one important point: not every patient is a good candidate for remote refractive care. Online testing is not meant for children, many older adults, people with symptoms, people with eye disease, and people with more complicated prescriptions. The American Academy of Ophthalmology has also taken a nuanced view, noting that home vision testing should be limited to healthy adults with mild or moderate prescriptions and no symptoms of eye disease. So the serious policy question is not whether comprehensive eye exams matter. They do. The real question is whether South Carolina’s answer is too blunt.
Why critics say the law blocks telemedicine innovation
Critics argue that South Carolina did not regulate this area with a scalpel. It used a cast-iron frying pan. Instead of allowing remote care for low-risk adults under defined safeguards, the state wrote a broad restriction that blocks prescriptions based solely on automated remote testing. That is a much bigger move than telling doctors to use good judgment. It is the legal equivalent of saying, “We trust telemedicine, except when we don’t, and especially not when it might be convenient.”
The Federal Trade Commission has repeatedly warned, in advocacy involving similar eye-care proposals, that rigid in-person exam mandates can reduce competition, limit consumer choice, raise costs, and slow innovation. The FTC’s reasoning is straightforward. Telehealth can lower travel burdens, help people with mobility challenges, expand access in underserved areas, and give patients more options for routine care. It can also support new delivery models, including store-and-forward systems and remote specialist review.
That is not just theory. Federal and state policy across health care increasingly moves toward digital prescription delivery, e-consults, remote evaluation of patient-submitted information, and patient access to prescriptions without unnecessary friction. The FTC’s Eyeglass Rule requires eye doctors to give patients a copy of their eyeglass prescription automatically after a refractive exam, and federal contact lens rules set a minimum one-year floor while still preserving prescription portability. The policy logic is clear: consumers should be able to access and use their vision prescriptions, not get trapped in a local retail loop.
South Carolina’s eye care law cuts against that trend. It does not simply require quality controls. It blocks a category of technology from serving as the sole basis for a prescription, even when a licensed clinician is reviewing the results. Critics say that is especially hard to justify in a state that otherwise presents telehealth as a way to erase geographic divides and expand care to underserved communities. South Carolina’s own Medicaid and telehealth reports celebrate telehealth’s ability to improve access, support follow-up care, and create more efficient specialty connections. Eye care is where the state suddenly decides the future can wait in the lobby.
The court settled the constitutional fight, not the policy fight
In January 2026, the South Carolina Supreme Court upheld the law. Legally, the court’s reasoning was narrow and unsurprising. Under rational-basis review, lawmakers get a lot of room. The court concluded that the legislature could reasonably believe in-person eye exams promote public health and help detect issues that automated refractive testing might miss. Once the case was framed that way, the challengers faced a very steep hill.
But here is the part that matters for policy readers, business leaders, and anyone who has ever tried to renew a glasses prescription between work meetings: the ruling did not prove that online vision testing is always unsafe, or that telemedicine has no role in refractive care. It simply held that South Carolina’s legislature was allowed to draw the line where it did. Courts often answer whether a law is constitutional, not whether it is smart, efficient, pro-innovation, or consumer-friendly. Those are different questions. South Carolina won the lawsuit, but that does not mean it won the argument.
In fact, the court itself acknowledged the speed at which artificial intelligence and related technologies are evolving and suggested that lawmakers may need to keep monitoring the policy rationale behind the law. Translation: this debate is not dead. It is just wearing judicial shoes now.
The deeper problem: regulating technology instead of regulating care
The biggest flaw in South Carolina’s approach is not that it values patient safety. Every serious telemedicine framework should. The flaw is that the law singles out a delivery method instead of building rules around clinical appropriateness. A modern regulatory model would ask whether the patient is low-risk, whether the provider has enough data, whether the technology has appropriate limitations and disclosures, whether red-flag symptoms trigger referral, and whether the doctor remains accountable for the decision. That is how mature telehealth policy usually works.
South Carolina already knows how to regulate that way. Its telemedicine law is built around standard of care. Its public health agencies discuss telehealth in terms of access, quality, and cost. Its telehealth ecosystem includes remote evaluation, e-consults, and specialty models that depend on digital information moving efficiently between patient and clinician. Then eye care gets a special rule that treats technology as suspect from the start. That mismatch is the real innovation killer.
When a state sends the message that a licensed doctor can prescribe some treatments remotely, can monitor conditions digitally, can review asynchronous information in other settings, but cannot use an online vision test as the sole basis for a routine corrective-lens prescription, innovators hear something very clearly: policy here may depend less on evidence than on who already owns the exam lane.
What smarter reform could look like
A better policy would not throw open the doors and let every phone screen become a stand-alone eye clinic. That would be sloppy. But South Carolina does not need to choose between no rules and a near-ban. There is a middle ground, and it is not hard to sketch.
1. Allow remote renewals for clearly defined, low-risk adults
Lawmakers could allow licensed clinicians to use remote refractive testing for prescription renewals in healthy adults who meet age and symptom criteria and who do not present with known ocular disease, red-flag symptoms, or complex histories.
2. Require strong disclosures
Every platform should plainly tell patients that a remote vision test is not a comprehensive eye exam and cannot diagnose many eye diseases. No tiny-font legal gymnastics. No cheerful fine print hiding behind a “continue” button.
3. Build in referral triggers
If the technology flags abnormal answers, rapid changes, contact lens concerns, or medical risk factors, the patient should be routed to in-person care. That is how telemedicine should work: convenience when appropriate, referral when necessary.
4. Preserve clinician accountability
The law should focus on the provider’s responsibility to meet the standard of care. If a clinician writes an inappropriate prescription, the answer is professional accountability, not a blanket ban on innovation.
5. Collect outcomes data
South Carolina could require reporting on adverse events, referral rates, patient satisfaction, and prescription accuracy. If lawmakers really want evidence-based policy, they should ask for evidence instead of freezing the market in place.
What this experience looks like in real life
To understand why this issue matters, it helps to step away from court opinions and trade-group talking points and look at how the law feels on the ground. For patients, the experience is often less dramatic than activists make it sound and more annoying than lawmakers seem to appreciate. Imagine a healthy adult in South Carolina whose glasses prescription has expired after a year. Their vision is a little blurrier, but they have no pain, no flashes, no diabetes, no prior eye disease, and no reason to believe they need a full medical workup right this minute. In another state, that person might complete a structured remote vision test, have a licensed doctor review the results, and get an appropriate renewal or a referral if something looks off. In South Carolina, that same person is pushed back into the traditional system, with all the scheduling friction, travel time, and lost convenience that telemedicine was designed to reduce.
For rural residents, busy parents, shift workers, college students, and people with limited transportation, that friction is not just irritating. It can become the reason care gets delayed. Sometimes “I’ll do it later” is just another way of saying “I can’t make the logistics work this month.” South Carolina’s own telehealth policy language recognizes that remote care can erase geographic divides and help underserved communities. But in vision care, the law tells those same people that convenience is suspicious.
Providers feel the strain differently. Some clinicians may want to use remote tools responsibly for follow-up or low-risk renewal cases, especially when they already know the patient or when the patient clearly falls into an appropriate screening category. Yet the law makes that kind of innovation legally risky or unavailable. So the clinician is left with fewer tools, not because the doctor cannot exercise judgment, but because the state has already exercised it for them. That is frustrating for professionals who are told in every other telehealth context to use evidence, documentation, and standard-of-care reasoning.
Then there is the startup experience, which is really the innovation experience. Companies do not just look at one statute; they look at the signal a statute sends. A state that welcomes telemedicine in general but carves out vision care in a way that blocks a specific kind of remote service looks unpredictable. Investors notice that. Founders notice that. Health systems notice that. The message is not merely “be safe.” The message is “you may build here, but only until your technology threatens an established revenue stream.” That is the sort of lesson that sends pilots, partnerships, and product launches somewhere else.
None of this means the old model has no value. Comprehensive eye exams remain essential. In-person care is not the villain here. The problem is the refusal to let routine, lower-risk, technology-assisted care exist alongside traditional care. Patients do not need a winner-take-all fight between the exam room and the smartphone. They need a system that uses each where it makes sense. Right now, South Carolina’s law treats that balanced approach like a dangerous experiment. In reality, the more dangerous experiment may be pretending that telemedicine innovation can thrive while one of the most common recurring health needs is fenced off from it.
Conclusion
South Carolina’s eye care laws were sold as patient protection. In practice, they also function as market protection. The state broadly accepts telemedicine when it follows the standard of care, yet it treats remote vision testing as a special threat when used to support corrective-lens prescriptions. That inconsistency is why the law keeps drawing criticism. It is not just about one company, one lawsuit, or one political fight from 2016. It is about whether a state can claim to support health care innovation while carving out an exception whenever innovation wanders too close to an incumbent business model.
South Carolina does not need to choose between safety and telemedicine innovation. It can have both. But it will have to stop regulating eye care like the internet is a rogue medical device with Wi-Fi and bad intentions. The smarter path is to regulate risk, preserve clinical judgment, require honest disclosures, and allow carefully bounded remote care where it makes sense. Until then, the state’s message to telemedicine innovators is simple: you may proceed, just not with your eyes open.
SEO Tags
